![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. N-phenylpiperazine
2. Phenylpiperazine
3. Phenylpiperazine Dihydrobromide
4. Phenylpiperazine Dihydrochloride
5. Phenylpiperazine Hydrochloride
6. Phenylpiperazine Monohydrochloride
1. 92-54-6
2. N-phenylpiperazine
3. Phenylpiperazine
4. Piperazine, 1-phenyl-
5. 1-phenyl-piperazine
6. N-phenyldiethylenediamine
7. 4-phenylpiperazine
8. N-phenyl Piperazine
9. 1-phenyl Piperazine
10. Chembl9434
11. J9225cbi7d
12. 1-fenylpiperazin
13. 1-fenylpiperazin [czech]
14. N-phenylpiperazin
15. Ccris 4334
16. Einecs 202-165-6
17. Brn 0132157
18. Unii-j9225cbi7d
19. 1-phenylpiperazinehydrochloride
20. Ai3-26332
21. Phenyl Piperazine
22. Phenyl-piperazine
23. 4-phenylpiperazin
24. N-phenylpiperizine
25. N-phenylpyperazine
26. 1-phenypiperazine
27. 4-phenylpiperizine
28. N-phenyl Piperazin
29. N Phenyl Piperazine
30. N-phenyl-piperazine
31. 4-phenyl Piperazine
32. 4-phenyl-piperazine
33. 1- Phenylpiperazine
34. Mfcd00005957
35. 1-n-phenylpiperazine
36. N'-phenyl-piperazine
37. 1-phenylpiperazine, 99%
38. Ec 202-165-6
39. Dsstox_cid_31644
40. Dsstox_rid_97528
41. Dsstox_gsid_57855
42. Schembl24889
43. Phenylpiperazine, 1-
44. 5-23-01-00160 (beilstein Handbook Reference)
45. Bidd:gt0830
46. Dtxsid8057855
47. Zinc120271
48. Act03613
49. Bcp22010
50. 1-phenylpiperazine 63921-23-3
51. Tox21_113878
52. Bbl027548
53. Bdbm50001898
54. Stl282711
55. Akos000119106
56. Ab00546
57. Ac-2107
58. Am81359
59. Cs-w019986
60. Lf-0549
61. Cas-92-54-6
62. Ncgc00253765-01
63. Db-027446
64. A4752
65. Bb 0295926
66. Ft-0631450
67. P0980
68. Levodropropizine Impurity B [ep Impurity]
69. Ae-641/30105013
70. Sr-01000944921
71. Q-100891
72. Q4862383
73. Sr-01000944921-1
74. F2190-0343
75. Levodropropizine Impurity B, European Pharmacopoeia (ep) Reference Standard
76. Vu9
Molecular Weight | 162.23 g/mol |
---|---|
Molecular Formula | C10H14N2 |
XLogP3 | 1.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 162.115698455 g/mol |
Monoisotopic Mass | 162.115698455 g/mol |
Topological Polar Surface Area | 15.3 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 124 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)